Long-Acting Injectable for HIV Gets Trial Wins

]]>(MedPage Today) -- Long-acting monthly injectable HIV therapy cabotegravir and rilpivirine was non-inferior to oral HIV antiretroviral therapy (ART), two phase III randomized trials found.Monthly injections of cabotegravir/rilpivirine as part...